BO
AZN icon

BRR OpCo’s AstraZeneca AZN Stock Holding History

BRR OpCo’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$211K Sell
1,923
-108
-5% -$13.7K 0.03% 206
2022
Q2 		$268K Buy
2,031
+399
+24% +$52.4K 0.03% 168
2022
Q1 		$217K Buy
+1,632
New +$196K 0.02% 203
2016
Q4 		– Sell
-8,362
Closed -$550K – 88
2016
Q3 		$550K Buy
8,362
+32
+0.4% +$2.09K 0.18% 69
2016
Q2 		$503K Buy
8,330
+339
+4% +$19.7K 0.17% 69
2016
Q1 		$450K Sell
7,991
-41
-0.5% -$2.46K 0.16% 70
2015
Q4 		$545K Sell
8,032
-165
-2% -$10.8K 0.2% 66
2015
Q3 		$522K Sell
8,197
-390
-5% -$25.7K 0.22% 64
2015
Q2 		$547K Buy
8,587
+252
+3% +$17.3K 0.22% 63
2015
Q1 		$570K Sell
8,335
-175
-2% -$12.2K 0.23% 60
2014
Q4 		$599K Sell
8,510
-205
-2% -$14.7K 0.24% 60
2014
Q3 		$623K Sell
8,715
-470
-5% -$34.4K 0.26% 62
2014
Q2 		$683K Sell
9,185
-6,250
-40% -$452K 0.29% 60
2014
Q1 		$1M Sell
15,435
-135
-0.9% -$8.72K 0.44% 44
2013
Q4 		$924K Sell
15,570
-70
-0.4% -$3.8K 0.4% 45
2013
Q3 		$812K Buy
15,640
+430
+3% +$21.6K 0.38% 52
2013
Q2 		$719K Buy
+15,210
New +$775K 0.35% 59

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

BRR OpCo's AZN Position: Q3 2022 in Review

BRR OpCo reduced its AstraZeneca (AZN) stake by 5.3% in Q3 2022, selling an estimated $13.7K and leaving 1,923 shares worth $211K. The position accounts for 0.03% of the portfolio, ranked #206.

BRR OpCo first reported a position in AZN in Q2 2013 and has held it in 17 quarters since. The position peaked at $1M in Q1 2014. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • BRR OpCo held 1,923 shares of AstraZeneca worth $211K as of Q3 2022.
  • BRR OpCo sold 108 AstraZeneca shares in Q3 2022, an estimated $13.7K.
  • AstraZeneca made up 0.03% of BRR OpCo's portfolio in Q3 2022, its #206 holding.
  • BRR OpCo first reported a position in AstraZeneca in Q2 2013 and has held it in 17 quarters since.
  • BRR OpCo's AstraZeneca position peaked at $1M in Q1 2014.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.